200 related articles for article (PubMed ID: 10997885)
1. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2000 Mar; 64(3):188-93. PubMed ID: 10997885
[TBL] [Abstract][Full Text] [Related]
2. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
3. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
4. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.
Carneskog J; Kutti J; Wadenvik H; Lundberg PA; Lindstedt G
Eur J Haematol; 1998 May; 60(5):278-82. PubMed ID: 9654156
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
Johansson P; Andréasson B
Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
[TBL] [Abstract][Full Text] [Related]
6. Increase of CD34 positive cells in polycythaemia vera.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 1997 Sep; 59(3):171-6. PubMed ID: 9310125
[TBL] [Abstract][Full Text] [Related]
7. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Lindstedt G; Stockelberg D; Wadenvik H; Kutti J
Leuk Lymphoma; 2001 May; 41(5-6):579-84. PubMed ID: 11378575
[TBL] [Abstract][Full Text] [Related]
8. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
9. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Andréasson B; Carneskog J; Lindstedt G; Lundberg PA; Swolin B; Wadenvik H; Kutti J
Leuk Lymphoma; 2000 Mar; 37(1-2):189-95. PubMed ID: 10721786
[TBL] [Abstract][Full Text] [Related]
10. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
11. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
Dai C; Chung IJ; Krantz SB
Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
[TBL] [Abstract][Full Text] [Related]
12. No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera.
Andersson P; LeBlanc K; Eriksson BA; Samuelsson J
Eur J Haematol; 1997 Nov; 59(5):310-7. PubMed ID: 9414643
[TBL] [Abstract][Full Text] [Related]
13. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.
Cella G; Marchetti M; Vianello F; Panova-Noeva M; Vignoli A; Russo L; Barbui T; Falanga A
Thromb Haemost; 2010 Jul; 104(1):151-6. PubMed ID: 20431848
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias.
Westwood NB; Pearson TC
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():95-103. PubMed ID: 8951779
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia.
Kralovics R; Prchal JT
Baillieres Clin Haematol; 1998 Dec; 11(4):803-18. PubMed ID: 10640218
[TBL] [Abstract][Full Text] [Related]
17. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
18. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
19. Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation.
Huang BT; Zeng QC; Zhao WH; Li BS; Chen RL
Leuk Res; 2014 Oct; 38(10):1177-83. PubMed ID: 25069759
[TBL] [Abstract][Full Text] [Related]
20. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
